editor, reviewer
154
edits
Changes
| name = Haloperidol
| group = Butyrophenones
| type = Antipsychotic
| CAS = 52-86-8
| ChemSpiderID = 3438
| ATC = N05AD01
| pubchem = 3559
| half drugbank = APRD00538
| medscape = 8661
| emea drugscom = haloperidol | therapy1 ftk = haloperidol| equivalent = 1| equivalent_ref = {{FTK-AP}}| comparison = haloperidol| avail = 60-70| therapyid1 avail_ref = <ref name= "informatorium">{{KNMP|haloperidol}}</ref>| therapyname1 halflife = 17.5| therapy2 halflife_ref = <ref name="pts">{{pts|3791}}</ref><ref name="informatorium" />| therapyid2 administration = O,IM,IV| therapyname2 dose = 0.25-15| ftk dose_ref = <ref name= Haloperidol"informatorium" />| othername1 DDD = 8| other1 DDD_ref = <ref>{{WHOCC|N05AD01}}</ref>| otherid1 ctox = 20| other2 ctox_ref = {{FTK-AP}}| otherid2 cth = 5| othername2 cth_ref = <ref name= "pts" />| type <includeonly> isswitch= Antipsychotic1</includeonly>
}}
